GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » OSE Immunotherapeutics SA (LTS:0RAD) » Definitions » Valuation Rank

OSE Immunotherapeutics (LTS:0RAD) Valuation Rank


View and export this data going back to 2015. Start your Free Trial

What is OSE Immunotherapeutics Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

OSE Immunotherapeutics Valuation Rank Related Terms

Thank you for viewing the detailed overview of OSE Immunotherapeutics's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

OSE Immunotherapeutics Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » OSE Immunotherapeutics SA (LTS:0RAD) » Definitions » Valuation Rank
Comparable Companies
XPAR:ALSEN XPAR:IVA XPAR:DBV XPAR:ALCLS XPAR:IPH XPAR:NANO XPAR:GNFT XPAR:TNG XPAR:MAAT XPAR:ADOC VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
OSE:France 6OP:Germany
Address
22, Boulevard Benoni Goullin, Nantes, FRA, 44200
Website
http://www.ose-immuno.com
OSE Immunotherapeutics SA is a France-based biotechnology company focused on the development of immunotherapies for immune activation and regulation in the fields of immuno-oncology and autoimmune diseases. The product portfolio of the company comprises Tedopi, OSE-172, OSE-703, FR104 and OSE-127.